Guardant360 CDx submitted for regulatory approval in Japan
Home » Guardant360 CDx submitted for regulatory approval in Japan

GH AMEA on Social MediaGuardant360 CDx submitted for regulatory approval in Japan
Guardant360 CDx submitted for regulatory approval in Japan
Guardant360 CDx submitted for regulatory approval in Japan
PR Newswire

In commemoration of World Cancer Day, we are delighted to announce that we have submitted our application for regulatory approval of Guardant360 CDx in Japan. See full press release here: https://lnkd.in/e3eQEmE

We commemorate World Cancer Day today with all our heroes – the Patients, the Oncologists, the Nurses and the Caregivers. Let’s conquer cancer together.

Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at [email protected] or contact us on WhatsApp: +65 8940 0360.

Guardant360®. Test. Take Action.

Message us